Performance share rights issue

14 September 2021 Performance share rights issue Blis Technologies Limited (Company) has issued performance share rights for no consideration to certain members of its senior leadership and senior management teams. The performance share rights were approved by the directors of the Company on 10 September 2021. The performance rights give the holder options to receive ordinary shares in the Company, which may be exercised if the performance rights vest. The vesting period is three years from the date the performance rights are granted, and vesting of the performance rights is conditional on the Company meeting certain compound annual growth targets set by the board in respect of its share price and net profit, and the continuous employment of the relevant holder. Ends For further information, please contact: Geoff Plunket Chair +64 21 229 8886 About Blis Technologies Ltd Delivering proven health benefits through evidence-based, advanced probiotics Blis Technologies is an NZX-listed manufacturer of advanced probiotic strains that go beyond the gut. Combining innovation with evidence-based research and the highest quality production controls enables the delivery of probiotic solutions for specific health targets including throat health, halitosis (bad breath), immune support, teeth and gum health and skin health. BLIS(R) products are sold throughout New Zealand and in Australia, Asia, Europe and the USA. More information about Blis Technologies Ltd can be found at www.blis.co.nz. Website: www.unconditionalskin.com Instagram: @unconditionalskin #BLISQ24 #USC Facebook: @unconditionalskin End CA:00379112 For:BLT Type:SECISSUE Time:2021-09-14 16:01:31